ABCA1 and type 2 diabetes mellitus: Since increased synthesis of cholesterol (Pihlajamäki et al., 2004) and downregulation of ABCA1 (Patel et al., 2011) is linked to type 2 diabetes FaDOH could have antidiabetic properties as a PPARγ agonist both by stimulating glucose uptake (El-Houri et al., 2015a) and increasing cholesterol removal through upregulation of ABCA1.